@article{bd45be45970b4ca59389f9aa634a53ec,
title = "Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014",
abstract = "The role of retroperitoneal lymph node dissection (RPLND) as first-line treatment for stage I or IIA/B testicular seminoma is not well defined. Using the National Cancer Data Base, we identified 365 men from 2004 to 2014 who received RPLND as primary treatment for testicular seminoma and found 5-year overall survival rates of 97.3\% and 92.0\% for those with stage I and IIA/B disease, respectively.",
keywords = "Outcomes, Overall survival, RPLND, Surgery, Testicular cancer",
author = "Tabakin, \{Alexandra L.\} and Shinder, \{Brian M.\} and Sinae Kim and Zorimar Rivera-Nunez and Polotti, \{Charles F.\} and Modi, \{Parth K.\} and Sterling, \{Joshua A.\} and Farber, \{Nicholas J.\} and Radadia, \{Kushan D.\} and Parikh, \{Rahul R.\} and Kim, \{Isaac Y.\} and Biren Saraiya and Mayer, \{Tina M.\} and Singer, \{Eric A.\} and Jang, \{Thomas L.\}",
note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",
year = "2020",
month = apr,
doi = "10.1016/j.clgc.2019.10.018",
language = "English",
volume = "18",
pages = "e194--e201",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier Inc.",
number = "2",
}